Scientific Reports , 11 (1)
Despite these promising results, the authors say they are a long way away from developing a drug for back pain based on this peptide, with one of many obstacles to overcome being formulation
This product is not intended to be used in combination with any peptide, compound, or any other product for the purpose of injection or any other form of administration to humans or animals
See preclinical dosing, mechanism, and body composition research
Rather than asking what is the dose, which presumes the compound is already the answer, the stronger questions open up the actual decision
Several cells appear to have the greatest demand for cyanocobalamin, particularly those that undergo rapid division such as bone marrow and epithelial cells.[5][7] Cyanocobalamin binds itself to plasma proteins in the systemic circulation